Abstract
Despite the distinction between ischemic stroke and neurodegenerative disorders, they share numerous pathophysiologies particularly those mediated by inflammation and oxidative stress. Although protein aggregation is considered to be a hallmark of neurodegenerative diseases, the formation of protein aggregates can be also induced within a short time after cerebral ischemia, aggravating cerebral ischemic injury. Protein aggregation uncovers a previously unappreciated molecular overlap between neurodegenerative diseases and ischemic stroke. Unfortunately, compared with neurodegenerative disease, mechanism of protein aggregation after cerebral ischemia and how this can be averted remain unclear. This review highlights current understanding on protein aggregation and its intrinsic role in ischemic stroke.
Similar content being viewed by others
References
Akutsu M, Dikic I, Bremm A (2016) Ubiquitin chain diversity at a glance. J Cell Sci 129(5):875–880
Alberts MJ (2017) Stroke treatment with intravenous tissue-type plasminogen activator: more proof that time is brain. Circulation 135(2):140–142
Alonso A, Zaidi T, Novak M et al (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 98(12):6923–6928
Ambadipudi S, Biernat J, Riedel D et al (2017) Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau. Nat Commun 8(1):275
An C, Shi Y, Li P et al (2014) Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair. Prog Neurobiol 115:6–24
Armakola M, Higgins MJ, Figley MD et al (2012) Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nat Genet 44(12):1302–1309
Atkin JD, Farg MA, Turner BJ et al (2006) Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1. J Biol Chem 281(40):30152–30165
Auluck PK, Chan HY, Trojanowski JQ et al (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295(5556):865–868
Ayala YM, De Conti L, Avendano-Vazquez SE et al (2011) TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 30(2):277–288
Bai Y, Zhang Y, Han B et al (2018) Circular RNA DLGAP4 ameliorates ischemic stroke outcomes by targeting miR-143 to regulate endothelial-mesenchymal transition associated with blood-brain barrier integrity. J Neurosci 38(1):32–50
Banani SF, Lee HO, Hyman AA et al (2017) Biomolecular condensates: organizers of cellular biochemistry. Nat Rev Mol Cell Biol 18(5):285–298
Banerjee K, Sinha M, Pham Cle L et al (2010) Alpha-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson's disease. FEBS Lett 584(8):1571–1576
Bendor JT, Logan TP, Edwards RH (2013) The function of alpha-synuclein. Neuron 79(6):1044–1066
Bendotti C, Marino M, Cheroni C et al (2012) Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: implication for protein aggregation and immune response. Prog Neurobiol 97(2):101–126
Bernassola F, Chillemi G, Melino G (2019) HECT-type E3 ubiquitin ligases in cancer. Trends Biochem Sci 44(12):1057–1075
Bi M, Gladbach A, van Eersel J et al (2017) Tau exacerbates excitotoxic brain damage in an animal model of stroke. Nat Commun 8(1):473
Bittar A, Bhatt N, Kayed R (2020) Advances and considerations in AD tau-targeted immunotherapy. Neurobiol Dis 134:104707
Blokhuis AM, Groen EJ, Koppers M et al (2013) Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol 125(6):777–794
Boeynaems S, Alberti S, Fawzi NL et al (2018) Protein phase separation: a new phase in cell biology. Trends Cell Biol 28(6):420–435
Brummitt RK, Nesta DP, Chang L et al (2011) Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms. J Pharm Sci 100(6):2104–2119
Buckley KM, Hess DL, Sazonova IY et al (2014) Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke. Exp Transl Stroke Med 6:8–8
Buetow L, Huang DT (2016) Structural insights into the catalysis and regulation of E3 ubiquitin ligases. Nat Rev Mol Cell Biol 17(10):626–642
Cabezas-Opazo FA, Vergara-Pulgar K, Perez MJ et al (2015) Mitochondrial dysfunction contributes to the pathogenesis of Alzheimer's disease. Oxid Med Cell Longev 2015:509654
Cadavid D, Mena H, Koeller K et al (2000) Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol 59(9):768–773
Caldeira MV, Curcio M, Leal G et al (2013) Excitotoxic stimulation downregulates the ubiquitin-proteasome system through activation of NMDA receptors in cultured hippocampal neurons. Biochim Biophys Acta 1832(1):263–274
Carloni S, Girelli S, Scopa C et al (2010) Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia. Autophagy 6(3):366–377
Catanese L, Tarsia J, Fisher M (2017) Acute ischemic stroke therapy overview. Circ Res 120(3):541–558
Cenini G, Voos W (2016) Role of mitochondrial protein quality control in oxidative stress-induced neurodegenerative diseases. Curr Alzheimer Res 13(2):164–173
Charidimou A, Gang Q, Werring DJ (2012) Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 83(2):124–137
Chauhan A, Sharma U, Jagannathan NR et al (2011) Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats. Behav Brain Res 225(2):603–609
Chaytow H, Huang YT, Gillingwater TH et al (2018) The role of survival motor neuron protein (SMN) in protein homeostasis. Cell Mol Life Sci 75(21):3877–3894
Chen X, Jiang H (2019) Tau as a potential therapeutic target for ischemic stroke. Aging 11(24):12827–12843
Chen X, Guan T, Li C et al (2012) SOD1 aggregation in astrocytes following ischemia/reperfusion injury: a role of NO-mediated S-nitrosylation of protein disulfide isomerase (PDI). J Neuroinflamm 9:237
Chung CY, Berson A, Kennerdell JR et al (2018) Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicity. Nat Commun 9(1):4406
Ciechanover A, Kwon YT (2017) Protein quality control by molecular chaperones in neurodegeneration. Front Neurosci 11:185
Civelek M, Mehrkens JF, Carstens NM et al (2019) Inhibition of mitophagy decreases survival of Caenorhabditis elegans by increasing protein aggregation. Mol Cell Biochem 452(1–2):123–131
Clarke PG, Puyal J (2012) Autophagic cell death exists. Autophagy 8(6):867–869
Cohen NR, Kayatekin C, Zitzewitz JA et al (2020) Friction-limited folding of disulfide-reduced monomeric SOD1. Biophys J 118(8):1992–2000
Corraini P, Henderson VW, Ording AG et al (2017) Long-term risk of dementia among survivors of ischemic or hemorrhagic stroke. Stroke 48(1):180–186
Currais A, Fischer W, Maher P et al (2017) Intraneuronal protein aggregation as a trigger for inflammation and neurodegeneration in the aging brain. FASEB J 31(1):5–10
D'Andrea L, Simon-Moya M, Llorente B et al (2018) Interference with Clp protease impairs carotenoid accumulation during tomato fruit ripening. J Exp Bot 69(7):1557–1568
David DC, Ollikainen N, Trinidad JC et al (2010) Widespread protein aggregation as an inherent part of aging in C. elegans. PLoS Biol 8(8):e1000450
DeGracia DJ, Hu BR (2007) Irreversible translation arrest in the reperfused brain. J Cereb Blood Flow Metab 27(5):875–893
de Oliveira GAP, Cordeiro Y, Silva JL et al (2019) Liquid-liquid phase transitions and amyloid aggregation in proteins related to cancer and neurodegenerative diseases. Adv Protein Chem Struct Biol 118:289–331
Deng Y, Chen D, Gao F et al (2020) Silencing of long non-coding RNA GAS5 suppresses neuron cell apoptosis and nerve injury in ischemic stroke through inhibiting DNMT3B-dependent MAP4K4 methylation. Transl Stroke Res
Deshaies JE, Shkreta L, Moszczynski AJ et al (2018) TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis. Brain 141(5):1320–1333
Deshpande J, Bergstedt K, Linden T et al (1992) Ultrastructural changes in the hippocampal CA1 region following transient cerebral ischemia: evidence against programmed cell death. Exp Brain Res 88(1):91–105
Di Carlo V, Grossi E, Laneve P et al (2013) TDP-43 regulates the microprocessor complex activity during in vitro neuronal differentiation. Mol Neurobiol 48(3):952–963
Ding X, Sun F, Chen J et al (2020) Amyloid-forming segment induces aggregation of FUS-LC domain from phase separation modulated by site-specific phosphorylation. J Mol Biol 432(2):467–483
Dolgin E (2018) What lava lamps and vinaigrette can teach us about cell biology. Nature 555(7696):300–302
Dong S, Maniar S, Manole MD et al (2018) Cerebral hypoperfusion and other shared brain pathologies in ischemic stroke and Alzheimer’s disease. Transl Stroke Res 9(3):238–250
Droppelmann CA, Campos-Melo D, Moszczynski AJ et al (2019) TDP-43 aggregation inside micronuclei reveals a potential mechanism for protein inclusion formation in ALS. Sci Rep 9(1):19928
Filipe V, Kukrer B, Hawe A et al (2012) Transient molten globules and metastable aggregates induced by brief exposure of a monoclonal IgG to low pH. J Pharm Sci 101(7):2327–2339
Freedman RB, Desmond JL, Byrne LJ et al (2017) 'Something in the way she moves': the functional significance of flexibility in the multiple roles of protein disulfide isomerase (PDI). Biochim Biophys Acta Proteins Proteom 1865(11):1383–1394
Freeze WM, Bacskai BJ, Frosch MP et al (2019) Blood-brain barrier leakage and microvascular lesions in cerebral amyloid angiopathy. Stroke 50(2):328–335
Galves M, Rathi R, Prag G et al (2019) Ubiquitin signaling and degradation of aggregate-prone proteins. Trends Biochem Sci 44(10):872–884
Gao YL, Wang N, Sun FR et al (2018) Tau in neurodegenerative disease. Ann Transl Med 6(10):175
Ge P, Luo Y, Liu CL et al (2007) Protein aggregation and proteasome dysfunction after brain ischemia. Stroke 38(12):3230–3236
Goulay R, Mena Romo L, Hol EM et al (2019) From stroke to dementia: a comprehensive review exposing tight interactions between stroke and amyloid-beta formation. Transl Stroke Res
Graham SH, Liu H (2017) Life and death in the trash heap: the ubiquitin proteasome pathway and UCHL1 in brain aging, neurodegenerative disease and cerebral Ischemia. Ageing Res Rev 34:30–38
Gregory RI, Yan KP, Amuthan G et al (2004) The Microprocessor complex mediates the genesis of microRNAs. Nature 432(7014):235–240
Guo T, Noble W, Hanger DP (2017) Roles of tau protein in health and disease. Acta Neuropathol 133(5):665–704
Gustot A, Gallea JI, Sarroukh R et al (2015) Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease. Biochem J 471(3):323–333
Haglund M, Passant U, Sjobeck M et al (2006) Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia. Int J Geriatr Psychiatry 21(7):681–687
Hankey GJ (2017) Stroke. Lancet 389(10069):641–654
Hatsuta H, Takao M, Nogami A et al (2019) Tau and TDP-43 accumulation of the basal nucleus of Meynert in individuals with cerebral lobar infarcts or hemorrhage. Acta Neuropathol Commun 7(1):49
Hayashi T, Takada K, Matsuda M (1991) Changes in ubiquitin and ubiquitin-protein conjugates in the CA1 neurons after transient sublethal ischemia. Mol Chem Neuropathol 15(1):75–82
Hayashi T, Takada K, Matsuda M (1992) Post-transient ischemia increase in ubiquitin conjugates in the early reperfusion. NeuroReport 3(6):519–520
Hochrainer K (2018) Protein modifications with ubiquitin as response to cerebral ischemia-reperfusion injury. Transl Stroke Res 9(2):157–173
Hochrainer K, Jackman K, Anrather J et al (2012) Reperfusion rather than ischemia drives the formation of ubiquitin aggregates after middle cerebral artery occlusion. Stroke 43(8):2229–2235
Hochrainer K, Jackman K, Benakis C et al (2015) SUMO2/3 is associated with ubiquitinated protein aggregates in the mouse neocortex after middle cerebral artery occlusion. J Cereb Blood Flow Metab 35(1):1–5
Hoffmann A, Ettle B, Bruno A et al (2016) Alpha-synuclein activates BV2 microglia dependent on its aggregation state. Biochem Biophys Res Commun 479(4):881–886
Hu BR, Martone ME, Jones YZ et al (2000) Protein aggregation after transient cerebral ischemia. J Neurosci 20(9):3191–3199
Hu BR, Janelidze S, Ginsberg MD et al (2001) Protein aggregation after focal brain ischemia and reperfusion. J Cereb Blood Flow Metab 21(7):865–875
Huang JJ, Li XN, Liu WL et al (2019) Neutralizing mutations significantly inhibit amyloid formation by human prion protein and decrease its cytotoxicity. J Mol Biol
Junn E, Lee KW, Jeong BS et al (2009) Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci USA 106(31):13052–13057
Kahl A, Blanco I, Jackman K et al (2018) Cerebral ischemia induces the aggregation of proteins linked to neurodegenerative diseases. Sci Rep 8(1):2701
Kaufman DM, Wu X, Scott BA et al (2017) Ageing and hypoxia cause protein aggregation in mitochondria. Cell Death Differ 24(10):1730–1738
Kent KP, Schroeder CE, Sharma C (2018) Solution pH jump during antibody and Fc-fusion protein thaw leads to increased aggregation. J Pharm Anal 8(5):302–306
Khalid MF, Damha MJ, Shuman S et al (2005) Structure-function analysis of yeast RNA debranching enzyme (Dbr1), a manganese-dependent phosphodiesterase. Nucleic Acids Res 33(19):6349–6360
Kia A, McAvoy K, Krishnamurthy K et al (2018) Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha. Glia 66(5):1016–1033
Kim T, Mehta SL, Kaimal B et al (2016) Poststroke induction of alpha-synuclein mediates ischemic brain damage. J Neurosci 36(26):7055–7065
Kim T, Mehta SL, Morris-Blanco KC et al (2018) The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing alpha-synuclein. Sci Signal 11(560):eaat4285
Kirino T, Tamura A, Sano K (1984) Delayed neuronal death in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol 64(2):139–147
Kovalska M, Tothova B, Kovalska L et al (2018) Association of induced hyperhomocysteinemia with Alzheimer's disease-like neurodegeneration in rat cortical neurons after global ischemia-reperfusion injury. Neurochem Res 43(9):1766–1778
Kwon YT, Ciechanover A (2017) The Ubiquitin code in the ubiquitin-proteasome system and autophagy. Trends Biochem Sci 42(11):873–886
Lam TI, Brennan-Minnella AM, Won SJ et al (2013) Intracellular pH reduction prevents excitotoxic and ischemic neuronal death by inhibiting NADPH oxidase. Proc Natl Acad Sci USA 110(46):E4362–4368
Lashuel HA, Overk CR, Oueslati A et al (2013) The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 14(1):38–48
Lee SO, Cho K, Cho S et al (2010) Protein disulphide isomerase is required for signal peptide peptidase-mediated protein degradation. EMBO J 29(2):363–375
Levy E, El Banna N, Baille D et al (2019) Causative links between protein aggregation and oxidative stress: a review. Int J Mol Sci 20(16):3896
Li Q, Zhang T, Wang J et al (2014) Rapamycin attenuates mitochondrial dysfunction via activation of mitophagy in experimental ischemic stroke. Biochem Biophys Res Commun 444(2):182–188
Li Y, Luo Y, Luo T et al (2017) Trehalose Inhibits protein aggregation caused by transient ischemic insults through preservation of proteasome activity, not via induction of autophagy. Mol Neurobiol 54(9):6857–6869
Li G, Morris-Blanco KC, Lopez MS et al (2018a) Impact of microRNAs on ischemic stroke: From pre- to post-disease. Prog Neurobiol 163–164:59–78
Li P, Stetler RA, Leak RK et al (2018b) Oxidative stress and DNA damage after cerebral ischemia: potential therapeutic targets to repair the genome and improve stroke recovery. Neuropharmacology 134(Pt B):208–217
Liang J, Yao J, Wang G et al (2012) Ischemic postconditioning protects neuronal death caused by cerebral ischemia and reperfusion via attenuating protein aggregation. Int J Med Sci 9(10):923–932
Liang Z, Wu G, Fan C et al (2016) The emerging role of signal transducer and activator of transcription 3 in cerebral ischemic and hemorrhagic stroke. Prog Neurobiol 137:1–16
Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443(7113):787–795
Lin Y, Protter DS, Rosen MK et al (2015) Formation and maturation of phase-separated liquid droplets by RNA-binding proteins. Mol Cell 60(2):208–219
Liu C, Chen S, Kamme F et al (2005a) Ischemic preconditioning prevents protein aggregation after transient cerebral ischemia. Neuroscience 134(1):69–80
Liu CL, Ge P, Zhang F et al (2005b) Co-translational protein aggregation after transient cerebral ischemia. Neuroscience 134(4):1273–1284
Liu F, Lu J, Manaenko A et al (2018) Mitochondria in ischemic stroke: new insight and implications. Aging Dis 9(5):924–937
Luo T, Park Y, Sun X et al (2013) Protein misfolding, aggregation, and autophagy after brain ischemia. Transl Stroke Res 4(6):581–588
Lyles MM, Gilbert HF (1991) Catalysis of the oxidative folding of ribonuclease A by protein disulfide isomerase: dependence of the rate on the composition of the redox buffer. Biochemistry 30(3):613–619
Magalhaes S, Trindade D, Martins T et al (2020) Monitoring plasma protein aggregation during aging using conformation-specific antibodies and FTIR spectroscopy. Clin Chim Acta 502:25–33
Martin DD, Ladha S, Ehrnhoefer DE et al (2015) Autophagy in Huntington disease and huntingtin in autophagy. Trends Neurosci 38(1):26–35
McMillan KJ, Murray TK, Bengoa-Vergniory N et al (2017) Loss of MicroRNA-7 regulation leads to alpha-synuclein accumulation and dopaminergic neuronal loss in vivo. Mol Ther 25(10):2404–2414
Mehta SL, Pandi G, Vemuganti R (2017) Circular RNA expression profiles alter significantly in mouse brain after transient focal ischemia. Stroke 48(9):2541–2548
Mitrea DM, Kriwacki RW (2016) Phase separation in biology; functional organization of a higher order. Cell Commun Signal 14:1
Murphy S (2000) Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia 29(1):1–13
Nguyen TM, Kabotyanski EB, Reineke LC et al (2019) The SINEB1 element in the long non-coding RNA Malat1 is necessary for TDP-43 proteostasis. Nucleic Acids Res
Pase MP, Himali JJ, Aparicio HJ et al (2019) Plasma total-tau as a biomarker of stroke risk in the community. Ann Neurol 86(3):463–467
Patel A, Malinovska L, Saha S et al (2017) ATP as a biological hydrotrope. Science 356(6339):753–756
Pavel M, Imarisio S, Menzies FM et al (2016) CCT complex restricts neuropathogenic protein aggregation via autophagy. Nat Commun 7:13821
Pluta R (2007) Role of ischemic blood-brain barrier on amyloid plaques development in Alzheimer's disease brain. Curr Neurovasc Res 4(2):121–129
Pluta R, Ulamek M, Jablonski M (2009) Alzheimer's mechanisms in ischemic brain degeneration. Anat Rec 292(12):1863–1881
Pluta R, Ulamek M, Jablonski M (2010) Consideration of the ischaemic basis and treatment of Alzheimer's disease. Folia Neuropathol 48(1):11–26
Pluta R, Bogucka-Kocka A, Ulamek-Koziol M et al (2018) Ischemic tau protein gene induction as an additional key factor driving development of Alzheimer's phenotype changes in CA1 area of hippocampus in an ischemic model of Alzheimer's disease. Pharmacol Rep 70(5):881–884
Ratti A, Buratti E (2016) Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J Neurochem 138(Suppl 1):95–111
Roman SG, Chebotareva NA, Kurganov BI (2017) Anti-aggregation activity of small heat shock proteins under crowded conditions. Int J Biol Macromol 100:97–103
Rother J (2008) Neuroprotection does not work! Stroke 39(2):523–524
Ryan VH, Dignon GL, Zerze GH et al (2018) Mechanistic view of hnRNPA2 low-complexity domain structure, interactions, and phase separation altered by mutation and arginine methylation. Mol Cell 69(3):465–479
Santos J, Iglesias V, Santos-Suarez J et al (2020) pH-dependent aggregation in intrinsically disordered proteins is determined by charge and lipophilicity. Cells 9(1):145
Sato Y, Tsuchiya H, Yamagata A et al (2019) Structural insights into ubiquitin recognition and Ufd1 interaction of Npl4. Nat Commun 10(1):5708
Schaser AJ, Osterberg VR, Dent SE et al (2019) Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders. Sci Rep 9(1):10919
Schwartz AL, Ciechanover A (2009) Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev Pharmacol Toxicol 49:73–96
Shorter J (2019) Phase separation of RNA-binding proteins in physiology and disease: an introduction to the JBC Reviews thematic series. J Biol Chem 294(18):7113–7114
Silva MC, Amaral MD, Morimoto RI (2013) Neuronal reprograming of protein homeostasis by calcium-dependent regulation of the heat shock response. PLoS Genet 9(8):e1003711
Skamris T, Tian X, Thorolfsson M et al (2016) Monoclonal antibodies follow distinct aggregation pathways during production-relevant acidic incubation and neutralization. Pharm Res 33(3):716–728
Soontornniyomkij V, Lynch MD, Mermash S et al (2010) Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy. Brain Pathol 20(2):459–467
Stoica G, Lungu G, Bjorklund NL et al (2012) Potential role of alpha-synuclein in neurodegeneration: studies in a rat animal model. J Neurochem 122(4):812–822
Stonesifer C, Corey S, Ghanekar S et al (2017) Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms. Prog Neurobiol 158:94–131
Suh J, Im DS, Moon GJ et al (2010) Hypoxic ischemia and proteasome dysfunction alter tau isoform ratio by inhibiting exon 10 splicing. J Neurochem 114(1):160–170
Sun Z, Diaz Z, Fang X et al (2011) Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol 9(4):e1000614
Swatek KN, Komander D (2016) Ubiquitin modifications. Cell Res 26(4):399–422
Tai HC, Besche H, Goldberg AL et al (2010) Characterization of the brain 26S proteasome and its interacting proteins. Front Mol Neurosci 3:12
Tokuda E, Furukawa Y (2017) Abnormal protein oligomers for neurodegeneration. Oncotarget 8(25):39943–39944
Toldo S, Severino A, Abbate A et al (2011) The role of PDI as a survival factor in cardiomyocyte ischemia. Methods Enzymol 489:47–65
Tsuiji H, Iguchi Y, Furuya A et al (2013) Spliceosome integrity is defective in the motor neuron diseases ALS and SMA. EMBO Mol Med 5(2):221–234
Vales-Montero M, Garcia-Pastor A, Iglesias-Mohedano AM et al (2019) Cerebral amyloid angiopathy-related transient focal neurological episodes: a transient ischemic attack mimic with an increased risk of intracranial hemorrhage. J Neurol Sci 406:116452
Vijayan M, Reddy PH (2016) Stroke, vascular dementia, and Alzheimer's disease: molecular links. J Alzheimers Dis 54(2):427–443
Wang W, Roberts CJ (2018) Protein aggregation—mechanisms, detection, and control. Int J Pharm 550(1–2):251–268
Wang P, Shao BZ, Deng Z et al (2018) Autophagy in ischemic stroke. Prog Neurobiol 163–164:98–117
Wang Y, Tian D, Wei C et al (2019) Propofol attenuates alpha-synuclein aggregation and neuronal damage in a mouse model of ischemic stroke. Neurosci Bull
Wegmann S, Eftekharzadeh B, Tepper K et al (2018) Tau protein liquid-liquid phase separation can initiate tau aggregation. EMBO J 37(7):e98049
Weids AJ, Grant CM (2014) The yeast peroxiredoxin Tsa1 protects against protein-aggregate-induced oxidative stress. J Cell Sci 127(Pt 6):1327–1335
Wen Y, Yang SH, Liu R et al (2007) Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim Biophys Acta 1772(4):473–483
Wolozin B (2019) The evolution of phase-separated TDP-43 in stress. Neuron 102(2):265–267
Wright RHG, Le Dily F, Beato M (2019) ATP, Mg(2+), nuclear phase separation, and genome accessibility. Trends Biochem Sci 44(7):565–574
Yamazaki T, Chen S, Yu Y et al (2012) FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Rep 2(4):799–806
Yau R, Rape M (2016) The increasing complexity of the ubiquitin code. Nat Cell Biol 18(6):579–586
Yedlapudi D, Xu L, Luo D et al (2019) Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: potential therapeutic application in Parkinson's disease with dementia. Sci Rep 9(1):19648
Zang J, Lu D, Xu A (2020) The interaction of circRNAs and RNA binding proteins: an important part of circRNA maintenance and function. J Neurosci Res 98(1):87–97
Zerna C, Thomalla G, Campbell BCV et al (2018) Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke. Lancet 392(10154):1247–1256
Zhang F, Liu CL, Hu BR (2006) Irreversible aggregation of protein synthesis machinery after focal brain ischemia. J Neurochem 98(1):102–112
Zhang HP, Yuan LB, Zhao RN et al (2010) Isoflurane preconditioning induces neuroprotection by attenuating ubiquitin-conjugated protein aggregation in a mouse model of transient global cerebral ischemia. Anesth Analg 111(2):506–514
Zhang X, Yan H, Yuan Y et al (2013) Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance. Autophagy 9(9):1321–1333
Zhang X, Yuan Y, Jiang L et al (2014) Endoplasmic reticulum stress induced by tunicamycin and thapsigargin protects against transient ischemic brain injury: involvement of PARK2-dependent mitophagy. Autophagy 10(10):1801–1813
Zhang HY, Wang ZG, Lu XH et al (2015) Endoplasmic reticulum stress: relevance and therapeutics in central nervous system diseases. Mol Neurobiol 51(3):1343–1352
Zhang X, Wesen E, Kumar R et al (2020) Correlation between cellular uptake and cytotoxicity of fragmented alpha-synuclein amyloid fibrils suggests intracellular basis for toxicity. ACS Chem Neurosci 11(3):233–241
Zhou Y, Liu S, Liu G et al (2013) ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLoS Genet 9(10):e1003895
Zhou J, Yu JT, Wang HF et al (2015) Association between stroke and Alzheimer's disease: systematic review and meta-analysis. J Alzheimers Dis 43(2):479–489
Zhou Z, Lu J, Liu WW et al (2018) Advances in stroke pharmacology. Pharmacol Ther 191:23–42
Funding
This study was supported by Grants from 2019 PhD Research Startup Fund of Affiliated Hospital of Yangzhou University (No. BS2019DLF).
Author information
Authors and Affiliations
Contributions
SW wrote the manuscript, Dr. LD provided constructive comments.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no competing financial interests to declare.
Research Involving Human and Animal Rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wu, S., Du, L. Protein Aggregation in the Pathogenesis of Ischemic Stroke. Cell Mol Neurobiol 41, 1183–1194 (2021). https://doi.org/10.1007/s10571-020-00899-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-020-00899-y